Cargando…
Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer
OBJECTIVE: Leucyl-tRNA synthetase (LRS) is an aminoacyl-tRNA synthetase catalyzing ligation of leucine to its cognate tRNA and is involved in the activation of mTORC1 by sensing cytoplasmic leucine. In this study, the usefulness of LRS as a therapeutic target of non-small cell lung cancer (NSCLC) an...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535710/ https://www.ncbi.nlm.nih.gov/pubmed/31205503 http://dx.doi.org/10.1177/1758835919846798 |
_version_ | 1783421610363977728 |
---|---|
author | Kim, Eun Young Lee, Jin Gu Lee, Jung Mo Kim, Arum Yoo, Hee Chan Kim, Kibum Lee, Minji Lee, Chulho Han, Gyoonhee Han, Jung Min Chang, Yoon Soo |
author_facet | Kim, Eun Young Lee, Jin Gu Lee, Jung Mo Kim, Arum Yoo, Hee Chan Kim, Kibum Lee, Minji Lee, Chulho Han, Gyoonhee Han, Jung Min Chang, Yoon Soo |
author_sort | Kim, Eun Young |
collection | PubMed |
description | OBJECTIVE: Leucyl-tRNA synthetase (LRS) is an aminoacyl-tRNA synthetase catalyzing ligation of leucine to its cognate tRNA and is involved in the activation of mTORC1 by sensing cytoplasmic leucine. In this study, the usefulness of LRS as a therapeutic target of non-small cell lung cancer (NSCLC) and the anticancer effect of the LRS inhibitor, BC-LI-0186, was evaluated. METHODS: LRS expression and the antitumor effect of BC-LI-0186 were evaluated by immunohistochemical staining, immunoblotting, and live cell imaging. The in vivo antitumor effect of BC-LI-0186 was evaluated using Lox-Stop-Lox (LSL) K-ras G12D mice. RESULTS: LRS was frequently overexpressed in NSCLC tissues, and its expression was positively correlated with mTORC1 activity. The guanosine-5’-triphosphate (GTP) binding status of RagB was related to the expression of LRS and the S6K phosphorylation. siRNA against LRS inhibited leucine-mediated mTORC1 activation and cell growth. BC-LI-0186 selectively inhibited phosphorylation of S6K without affecting phosphorylation of AKT and leucine-mediated co-localization of Raptor and LAMP2 in the lysosome. BC-LI-0186 induced cleaved poly (ADP-ribose) polymerase (PARP) and caspase-3 and increase of p62 expression, showing that it has the autophagy-inducing property. BC-LI-0186 has the cytotoxic effect at nanomolar concentration and its GI(50) value was negatively correlated with the degree of LRS expression. BC-LI-0186 showed the antitumor effect, which was comparable with that of cisplatin, and mTORC1 inhibitory effect in a lung cancer model. CONCLUSIONS: BC-LI-0186 inhibits the noncanonical mTORC1-activating function of LRS. These results provide a new therapeutic strategy for NSCLC and warrant future clinical development by targeting LRS. |
format | Online Article Text |
id | pubmed-6535710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-65357102019-06-14 Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer Kim, Eun Young Lee, Jin Gu Lee, Jung Mo Kim, Arum Yoo, Hee Chan Kim, Kibum Lee, Minji Lee, Chulho Han, Gyoonhee Han, Jung Min Chang, Yoon Soo Ther Adv Med Oncol Original Research OBJECTIVE: Leucyl-tRNA synthetase (LRS) is an aminoacyl-tRNA synthetase catalyzing ligation of leucine to its cognate tRNA and is involved in the activation of mTORC1 by sensing cytoplasmic leucine. In this study, the usefulness of LRS as a therapeutic target of non-small cell lung cancer (NSCLC) and the anticancer effect of the LRS inhibitor, BC-LI-0186, was evaluated. METHODS: LRS expression and the antitumor effect of BC-LI-0186 were evaluated by immunohistochemical staining, immunoblotting, and live cell imaging. The in vivo antitumor effect of BC-LI-0186 was evaluated using Lox-Stop-Lox (LSL) K-ras G12D mice. RESULTS: LRS was frequently overexpressed in NSCLC tissues, and its expression was positively correlated with mTORC1 activity. The guanosine-5’-triphosphate (GTP) binding status of RagB was related to the expression of LRS and the S6K phosphorylation. siRNA against LRS inhibited leucine-mediated mTORC1 activation and cell growth. BC-LI-0186 selectively inhibited phosphorylation of S6K without affecting phosphorylation of AKT and leucine-mediated co-localization of Raptor and LAMP2 in the lysosome. BC-LI-0186 induced cleaved poly (ADP-ribose) polymerase (PARP) and caspase-3 and increase of p62 expression, showing that it has the autophagy-inducing property. BC-LI-0186 has the cytotoxic effect at nanomolar concentration and its GI(50) value was negatively correlated with the degree of LRS expression. BC-LI-0186 showed the antitumor effect, which was comparable with that of cisplatin, and mTORC1 inhibitory effect in a lung cancer model. CONCLUSIONS: BC-LI-0186 inhibits the noncanonical mTORC1-activating function of LRS. These results provide a new therapeutic strategy for NSCLC and warrant future clinical development by targeting LRS. SAGE Publications 2019-05-19 /pmc/articles/PMC6535710/ /pubmed/31205503 http://dx.doi.org/10.1177/1758835919846798 Text en © The Author(s), 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Kim, Eun Young Lee, Jin Gu Lee, Jung Mo Kim, Arum Yoo, Hee Chan Kim, Kibum Lee, Minji Lee, Chulho Han, Gyoonhee Han, Jung Min Chang, Yoon Soo Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer |
title | Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer |
title_full | Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer |
title_fullStr | Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer |
title_full_unstemmed | Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer |
title_short | Therapeutic effects of the novel Leucyl-tRNA synthetase inhibitor BC-LI-0186 in non-small cell lung cancer |
title_sort | therapeutic effects of the novel leucyl-trna synthetase inhibitor bc-li-0186 in non-small cell lung cancer |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535710/ https://www.ncbi.nlm.nih.gov/pubmed/31205503 http://dx.doi.org/10.1177/1758835919846798 |
work_keys_str_mv | AT kimeunyoung therapeuticeffectsofthenovelleucyltrnasynthetaseinhibitorbcli0186innonsmallcelllungcancer AT leejingu therapeuticeffectsofthenovelleucyltrnasynthetaseinhibitorbcli0186innonsmallcelllungcancer AT leejungmo therapeuticeffectsofthenovelleucyltrnasynthetaseinhibitorbcli0186innonsmallcelllungcancer AT kimarum therapeuticeffectsofthenovelleucyltrnasynthetaseinhibitorbcli0186innonsmallcelllungcancer AT yooheechan therapeuticeffectsofthenovelleucyltrnasynthetaseinhibitorbcli0186innonsmallcelllungcancer AT kimkibum therapeuticeffectsofthenovelleucyltrnasynthetaseinhibitorbcli0186innonsmallcelllungcancer AT leeminji therapeuticeffectsofthenovelleucyltrnasynthetaseinhibitorbcli0186innonsmallcelllungcancer AT leechulho therapeuticeffectsofthenovelleucyltrnasynthetaseinhibitorbcli0186innonsmallcelllungcancer AT hangyoonhee therapeuticeffectsofthenovelleucyltrnasynthetaseinhibitorbcli0186innonsmallcelllungcancer AT hanjungmin therapeuticeffectsofthenovelleucyltrnasynthetaseinhibitorbcli0186innonsmallcelllungcancer AT changyoonsoo therapeuticeffectsofthenovelleucyltrnasynthetaseinhibitorbcli0186innonsmallcelllungcancer |